Authors: Lubbert, M Wijermans, P Kunzmann, R Verhoef, G Bosly, A Ravoet, C Andre, M Ferrant, A

Citation: M. Lubbert et al., Cytogenetic responses in high-risk myelodysplastic syndrome following low-dose treatment with the DNA methylation inhibitor 5-aza-2 '-deoxycytidine, BR J HAEM, 114(2), 2001, pp. 349-357

Authors: Wasch, R Reisser, S Hahn, J Bertz, H Engelhardt, M Kunzmann, R Veelken, H Holler, E Finke, J

Citation: R. Wasch et al., Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan andallogeneic transplantation, BONE MAR TR, 26(3), 2000, pp. 243-250

Authors: Finke, J Bertz, H Schmoor, C Veelken, H Behringer, D Wasch, R Kunzmann, R Heidecker, L Lang, H Meyer-Konig, U Mertelsmann, R

Citation: J. Finke et al., Allogeneic bone marrow transplantation from unrelated donors using in vivoanti-T-cell globulin, BR J HAEM, 111(1), 2000, pp. 303-313

Authors: Wasch, R Bertz, H Kunzmann, R Finke, J

Citation: R. Wasch et al., Incidence of mixed chimaerism and clinical outcome in 101 patients after myeloablative conditioning regimens and allogeneic stem cell transplantation, BR J HAEM, 109(4), 2000, pp. 743-750

Authors: Lahn, M Fisch, P Kohler, G Kunzmann, R Hentrich, I Jesuiter, H Behringer, D Muschal, B Veelken, H Kulmburg, P Ikle, DN Lindemann, A

Citation: M. Lahn et al., Pro-inflammatory and T cell inhibitory cytokines are secreted at high levels in tumor cell cultures of human renal cell carcinoma, EUR UROL, 35(1), 1999, pp. 70-80